Phase 4 Liver Cancer Trial, Recruiting NCT06353126 Sponsor: RenJi Hospital Condition: Liver Cancer
Back to Liver Cancer

Phase 4 Liver Cancer Trial, Recruiting

NCT06353126
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with liver cancer linked to viral hepatitis or cirrhosis, confirmed through scans (such as CT or MRI) or a tissue sample/biopsy, following specific medical guidelines
  • Your liver function has been rated as reasonably well-preserved (Child-Pugh score A or B — confirm with trial site)
  • Your tumor is located in the right side of the liver
  • Your liver cancer meets the "up to seven" rule, meaning the total of your tumor size (in cm) plus the number of tumors does not exceed 7
  • Your general health and activity level are good to moderately good (ECOG score 0–1 — confirm with trial site)
  • You are already planning to have a living donor liver transplant as your main treatment
  • You are willing and able to sign a consent form to take part

Who may not be able to join:

  • You have cancer that has spread into major blood vessels near the liver or into the main bile duct
  • You have severe confusion or brain problems caused by liver disease (hepatic encephalopathy)
  • You have moderate to severe high blood pressure in the lungs (pulmonary arterial hypertension, WHO Grade III–IV)
  • You have had a serious allergic reaction to contrast dye used in scans
  • You have a permanent abnormal connection between certain blood vessels in your liver (confirm with trial site)
  • You have a specific uncommon variation in the structure of your portal vein (confirm with trial site)
  • Your cancer has spread to areas outside the liver
  • You currently have active hepatitis or a serious ongoing infection
  • Your cancer has spread widely and your expected survival is less than 3 months
  • Your kidneys are not working well enough (based on specific blood test results — confirm with trial site)
  • Your white blood cell count or platelet count is too low and cannot be improved with treatment
  • You are not healthy enough to safely undergo surgery and general anesthesia (due to serious heart, lung, or brain/stroke conditions)
  • You have a serious mental health condition
  • The trial doctors have another reason they feel makes participation unsuitable for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Jianjun Zhang, MD, RenJi Hospital

Phone: 13621621415

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Registry
ClinicalTrials.gov
Start date
16 October 2024
Est. completion
1 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Recurrence-free survival (RFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov